Tumor necrosis factor superfamily ligands (TNF)

LY 303511 hydrochloride is a structural analogue of LY294002. LY303511 does not inhibit PI3K . LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells. LY303511 reversibly blocks K + currents (IC 50 =64.6±9.1 μM) in MIN6 insulinoma

LY 303511 hydrochloride is a structural analogue of LY294002. LY303511 does not inhibit PI3K . LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells. LY303511 reversibly blocks K + currents (IC 50 =64.6±9.1 μM) in MIN6 insulinoma

LY 303511 hydrochloride is a structural analogue of LY294002. LY303511 does not inhibit PI3K . LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells. LY303511 reversibly blocks K + currents (IC 50 =64.6±9.1 μM) in MIN6 insulinoma

lymphotoxin β₂α₁ heterotrimer

lymphotoxin β₂α₁ heterotrimer

lymphotoxin-α

lymphotoxin-α

lymphotoxin-β

lymphotoxin-β

Negletein is a neuroprotectant enhances the action of nerve growth factor and induces neurite outgrowth in PC12 cells. Negletein shows promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC 50 values of 16.4 and 10.8 μM,

Negletein is a neuroprotectant enhances the action of nerve growth factor and induces neurite outgrowth in PC12 cells. Negletein shows promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC 50 values of 16.4 and 10.8 μM,

Negletein is a neuroprotectant enhances the action of nerve growth factor and induces neurite outgrowth in PC12 cells. Negletein shows promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC 50 values of 16.4 and 10.8 μM,